BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 7010558)

  • 1. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli 06 infection in mice. 1. Effect of immunisation on resistance in relation to 06 antibody levels in mice of different strains.
    Ahlstedt S
    Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):39-45. PubMed ID: 6990690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Escherichia coli 06 infection in mice. IV. On the relative importance of complement factors and antibodies for the host defence.
    Ahlstedt S
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):23-8. PubMed ID: 7027735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Escherichia coli 06 infection in mice. III. Effects of malnutrition, immunization and nutritional restoration.
    Ahlstedt S
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):15-22. PubMed ID: 7027734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant mouse model of E. coli diarrhoea: clinical protection induced by vaccination of the mothers.
    Duchet-Suchaux M
    Ann Rech Vet; 1983; 14(3):319-31. PubMed ID: 6362544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity of the skin--infection and percutaneous immunization of rabbits with E. coli ATCC 13676].
    Hammerschmidt W; Hellmann E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):252-67. PubMed ID: 3892981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide-induced specific suppression of the protective immune response to rodent malaria.
    Wells RA; Diggs CL; Phillips SM
    J Immunol; 1977 Feb; 118(2):472-7. PubMed ID: 65425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization.
    Hafizi A; Modabber FZ
    Clin Exp Immunol; 1978 Sep; 33(3):389-94. PubMed ID: 737894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
    Kariyawasam S; Wilkie BN; Gyles CL
    Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay for detection of antibodies against Escherichia coli: association between indirect hemagglutination test and survival.
    Leitner G; Melamed D; Drabkin N; Heller ED
    Avian Dis; 1990; 34(1):58-62. PubMed ID: 2181997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B; Sadowski W; Kańtoch M
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse.
    Kerckhaert JA; Hofhuis FM; Willers JM
    Immunology; 1977 Jun; 32(6):1027-32. PubMed ID: 885586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of fosfomycin on cellular immune reactions as affected by cyclophosphamide or corticosteroids].
    Gillissen G; Breuer-Werle M; Ostendorp H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):731-4. PubMed ID: 3054757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
    Pier GB; Markham RB
    J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.